The Food and Drug Administration Friday authorized for emergency use a real-time polymerase chain reaction test to detect mpox (formerly known as monkeypox) in lesion swab specimens from individuals whose health care provider suspects they have the virus. Only laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 to perform high or moderate complexity tests may perform the test. For more, see the fact sheet for health care providers.

In other news, FDA last week released an update on medical device reports associated with certain Philips Respironics ventilators, BiPAP machines, and CPAP machines recalled in June 2021, which include 346 deaths reportedly associated with the breakdown or suspected breakdown of polyester-based polyurethane foam used in the devices.

Related News Articles

Headline
The Department of Health and Human Services July 28 announced the creation of a $100 million pilot program to prevent, test for, treat and cure hepatitis C for…
Headline
Five pediatric flu deaths were reported to the Centers for Disease Control and Prevention last week, pushing the total to 266 for the 2024-2025 flu season,…
Headline
The Department of Health and Human Services July 23 announced it is recommending the removal of thimerosal from all U.S. flu vaccines. The announcement follows…
Headline
The Centers for Disease Control and Prevention July 7 announced it is streamlining H5N1 bird flu updates with its routine influenza data given the low public…
Headline
The United States July 7 reached its highest annual measles case tally in 33 years, hitting at least 1,277 confirmed cases across 38 states and the District of…
Headline
The Administration for Strategic Preparedness and Response June 25 announced it conducted an exercise transporting simulated patients with high-consequence…